1. Neuronal Signaling GPCR/G Protein Stem Cell/Wnt MAPK/ERK Pathway
  2. Sigma Receptor mAChR ERK Amyloid-β Tau Protein
  3. AF710B

AF710B is an orally effective allosteric agonist for the M1 muscarinic receptor and σ1 receptor. AF710B activates the downstream phosphorylated ERK1/2 and phosphorylated CREB signaling pathways. AF710B simultaneously improves cognitive function and alleviates the core pathological features of Alzheimer's disease, including deposition, excessive Tau phosphorylation and neuroinflammation. AF710B is applicable to the research of Alzheimer's disease.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

AF710B

AF710B 構造式

容量 在庫状況
50 mg   お問い合わせ  
100 mg   お問い合わせ  
250 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

Other Forms of AF710B:

Top Publications Citing Use of Products

Sigma Receptor アイソフォーム固有の製品をすべて表示:

mAChR アイソフォーム固有の製品をすべて表示:

ERK アイソフォーム固有の製品をすべて表示:

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

AF710B is an orally effective allosteric agonist for the M1 muscarinic receptor and σ1 receptor. AF710B activates the downstream phosphorylated ERK1/2 and phosphorylated CREB signaling pathways. AF710B simultaneously improves cognitive function and alleviates the core pathological features of Alzheimer's disease, including deposition, excessive Tau phosphorylation and neuroinflammation. AF710B is applicable to the research of Alzheimer's disease[1].

体外実験

AF710B (0.1-10 nM; 3 h) potentiates carbachol-induced ERK1/2 and CREB phosphorylation in starved PC12M1 cells without inducing these responses independently[1].
AF710B (30 nM; 16 h) rescues mushroom spine loss in PS1-KI and APP-KI primary hippocampal neuronal cultures via a mechanism requiring functional M1 mAChRs and intact σ1R expression, with no effect on nTg cultures[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: rat pheochromocytoma PC12 cells stably transfected with rat M1 mAChR (PC12M1 cells)
Concentration: 0.1, 1 and 10 nM
Incubation Time: 3 h (pretreatment); 10 min (carbachol treatment)
Result: Did not increase phospho-ERK1/2 or phospho-CREB levels independently.
Significantly potentiated carbachol-induced phosphorylation of ERK1/2 and CREB at all tested concentrations.
体内実験

AF710B (1-30 µg/kg; p.o.; single administration) significantly attenuates trihexyphenidyl (HY-B1277A)-induced cognitive impairment in rats[1].
AF710B (10 µg/kg; i.p.; once daily for 2 months) improves cognitive function in mice, and reduces Aβ pathology, excessive tau phosphorylation, and neuroinflammation[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Wistar (male and female, 3 months old, 225-250 gr, trihexyphenidyl-induced cognitive impairment)[1]
Dosage: 1 µg/kg; 3 µg/kg; 10 µg/kg; 30 µg/kg; 100 µg/kg
Administration: p.o.; single dose
Result: Significantly increased retention latency in trihexyphenidyl-treated rats compared to vehicle-treated trihexyphenidyl rats at 1, 3, 10, and 30 µg/kg doses.
Showed no significant effect at 100 µg/kg dose.
Demonstrated higher potency at 10 µg/kg dose than 100 µg/kg dose.
Lost anti-amnesic effect at 10 µg/kg dose when coadministered with σ1R antagonist NE-100.
Animal Model: 129/C57BL/6 (female, 10-12 months old, 3xTg-AD Alzheimer's disease model)[1]
Dosage: 10 µg/kg
Administration: i.p.; daily; 2 months
Result: Improved cognitive function, as shown by decreased escape latency during Morris water maze training and increased time spent in the target quadrant during the probe trial.
Significantly reduced levels of soluble and insoluble Aβ40 and Aβ42, and decreased Thioflavin S-positive amyloid plaques.
Lowered BACE1 expression and levels of the β-secretase-derived APP C-terminal fragment C99, while leaving full-length APP and α-secretase (ADAM10, ADAM17) levels unchanged.
Reduced total phosphorylated tau (AT-100 epitope) and specific phospho-tau epitopes (AT180, AT270, PHF-1), while total tau levels remained unchanged.
Increased inhibitory Ser9 phosphorylation of GSK3β and reduced levels of the CDK5 activator p25.
Decreased neuroinflammation, as shown by reduced GFAP-positive astrocytes and Iba-1-positive microglia in the vicinity of Aβ plaques.
分子量

357.51

分子式

C20H27N3OS

SMILES

C[C@@H]1SC2(CN1C(CCC3=CNC4=C3C=CC=C4)=O)CCN(CC2)C

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション
参考文献
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
AF710B
製品番号:
HY-116586
数量:
MCE 日本正規代理店: